Ourotech competitors

Ourotech Competitors include Heat Biologics, Cleveland BioLabs, Geron and Aeglea Biotherapeutics.
Add company...
Ourotech
Ourotech
Ourotech is changing the way cancer drugs are tested for the most innovative treatments.
Heat Biologics
Heat Biologics
Heat Biologics is a clinical-stage company focused on developing its proprietary “ImPACT” (Immune Pan-Antigen Cytotoxic Therapy) fully allogeneic “off-the-shelf” cell based immunotherapy to treat patients with a wide array of cancers and infectious diseases.
Cleveland BioLabs
Cleveland BioLabs
CBLI’s mission is to develop and commercialize innovative drugs to treat cancer and protect healthy tissues from radiation, chemotherapy or ischemic conditions.
Geron
Geron
Geron is a clinical stage biopharmaceutical company focused on the development of a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.
Aeglea Biotherapeutics
Aeglea Biotherapeutics
Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics in the field of amino acid metabolism to treat rare genetic diseases and cancer.
Founding Date
Founding Date
2015
Founding Date
2008
Founding Date
2003
Founding Date
1990
Founding Date
2013
Type
Type
Private
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Waterloo, CA HQ
Locations
Durham, US HQ
Locations
Buffalo, US HQ
Locations
Menlo Park, US HQ
Canton, US
Locations
Austin, US HQ
Employees
Employees
3
Employees
19
Employees
12
Employees
15
Employees
5612% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
48 m
Valuation ($)
15.7 m
Valuation ($)
290.7 m
Valuation ($)
200.6 m

Financial

Net income
Net income
N/A
Net income
($12.4m) (FY, 2017)
Net income
($9.8m) (FY, 2017)
Net income
($27.9m) (FY, 2017)
Net income
($27.2m) (FY, 2017)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 12.2m
Total funding raised
$ 96.7m
Total funding raised
N/A
For sources of this data, please see the company profileDownload Excel

View company profiles

Heat Biologics
HQ
Durham, US
Employees
19

Heat Biologics is a clinical-stage company focused on developing its proprietary “ImPACT” (Immune Pan-Antigen Cytotoxic Therapy) fully allogeneic “off-the-shelf” cell based immunotherapy to treat patients with a wide array of cancers and infectious diseases.

View company
Cleveland BioLabs
HQ
Buffalo, US
Employees
12

CBLI’s mission is to develop and commercialize innovative drugs to treat cancer and protect healthy tissues from radiation, chemotherapy or ischemic conditions.

View company
Geron
HQ
Menlo Park, US
Employees
15

Geron is a clinical stage biopharmaceutical company focused on the development of a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.

View company
Aeglea Biotherapeutics
HQ
Austin, US
Employees
56↑ 12% increase

Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics in the field of amino acid metabolism to treat rare genetic diseases and cancer.

View company